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Abstract 
Background: Breast cancer is the second most common cancer detected in the world, as reported 
by GLOBOCAN in 2012 and contribute about 25% of overall cancer worldwide. In Kelantan, it 
had been reported by Cancer Registry 2006, up to 34.9% cases presented at stage 4, comparing 
only 20.7% in stage 3 and 19% in stage 1. The aim of this study is to understand the factor 
associated with delay in seeking treatment for patient presented with locally advanced and 
metastatic breast cancer in HRPZ II. 
Methods: This is a cross-sectional study regarding patient who are being diagnosed as locally 
advanced and metastatic breast cancer in HRPZ II, Kelantan from January 2016 till December 
2019. Patients were interviewed face to face using a standardized questionnaire. We exclude 
patient who had cognitive impairment, or who had early breast cancer but presented with 
recurrence disease or did not have proper documentation of investigation.  
Results: A total of 111 patients are diagnosed as either locally advanced or metastatic breast cancer 
were interviewed.  Patients thought that the breast lump will disappear by itself and afraid of the 
pain related to cancer and operation found to be the factors associated with delay in seeking 
treatment among locally advanced and metastatic breast cancer. The adjusted odds ratio for both 
factors was 3.13 (95% CI 1.19 – 8.20) and O.37 (95% CI 0.16 – 0.88) respectively. 
Conclusion:Patient thought that the breast lump will disappear by itself and afraid of the pain 
related cancer and operation are the significant independent factors that associated with delay in 
seeking treatment among locally advanced and metastatic breast cancer. 
Keyword: Delay locally advanced breast cancer, metastatic breast cancer 
 
Abstrak 
Latar Belakang: Mengikut kajian GLOBOCAN pada tahun 2012, kanser payudara merupakan 
kanser yang kedua terbanyak dikesan di dunia dan merangkumi 25% dari jumlah keseluruhan 
kanser di dunia. Di Kelantan, mengikut laporan Pendaftaran Kanser 2006, sebanyak 34.9% pesakit 
kanser payudara hadir ke hospital pada tahap 4, berbanding 20.7% pada tahap 3 dan 19% ada tahap 
1. Tujuan kajian ini adalah untuk mengenal pasti faktor-faktor yang berkaitrapat dengan kelewatan 
pesakit mendapatkan rawatan di Hospital Raja Perempuan Zainab II (HRPZ II).  
Kaedah Kajian: Ini adalah kajian rentas bagi pesakit kanser payudara “locally advanced” dan 
“metastatic” yang didiagnos di HRPZ II dari Januari 2016 sehingga December 2019. Pesakit di 
temuduga menggunakan kertas soal-selidik yang diseragamkan. Pesakit yang mengalami 
kecacatan kognitif atau kanser payudara peringkat awal tetapi kembali kerana kanser berulang atau 
pesakit tidak mempunyai nota rawatan yang lengkap akan dikecualikan dari kajian ini. 
Keputusan Kajian: Sejumlah 111 pesakit kanser payudara “metastatic” dan “locally advanced” 
telah di temuduga. Tanggapan pesakit yang ketumbuhan payudara akan hilang sendiri dan 
ketakutan mengenai kesakitan berkaitan dengan kanser dan pembedahan merupakan factor yang 
tidak bersandar menyebabkan kelewatan mendapatkan rawatan. Nisbah kebarangkalian yang 
disesuaikan bagi kedua-dua factor tersebut adalah 3.13 (95% CI 1.19 – 8.20) dan 0.37 (95%CI 
0.16 – 0.88). 
Konklusi: Anggapan pesakit yang ketumbuhan payudara akan hilang sendiri dan ketakutan 
mengenai kesakitan berkaitan dengan kanser dan pembedahan merupakan faktor yang tidak 
bersandar menyebabkan kelewatan mendapatkan rawatan bagi kanser payudara “metastatic” dan 
“locally advanced”. 
Keyword: Delay locally advanced breast cancer, metastatic breast cancer 
 
1.1 Introduction: 
Breast cancer is the second most common cancer detected in the world, as reported by 
GLOBOCAN in 2012 and contribute about 25% of overall cancer worldwide.1 It expected to 
increase every year as a lot of promotion had been done to increase breast cancer awareness. 
Despite the public awareness and education regarding breast cancer, patient with locally advanced 
breast cancer or metastatic breast cancer are till commonly seen in our community.  
 
In Kelantan, it had been reported by the National Cancer Registry 2006, up to 34.9% cases 
presented at stage 4, comparing only 20.7% in stage 3 and 19% in stage 1.2 Breast cancer is a 
disease that has good survival rate if detected early as delay in seeking treatment associated with 
the larger tumour, more advanced stage and subsequently poorer prognosis. Locally advanced 
breast cancer can be defined as breast cancer that have more than 5 cm in size with regional 
lymphadenopathy, or tumour that have direct extension to the chest wall or skin or both, or 
presence of regional lymphadenopathy (clinically fixed or mattered lymph nodes or infraclavicular, 
supraclavicular, or internal mammary involvement). Whereas metastatic breast cancer is defined 
as any breast cancer that have spread to other organ.  
 
Breast cancer delay can be defined as more than 12 weeks between the discovery of the 
symptom by the patient and the beginning of the definitive treatment.  This can be further classified 
as patient delay (waiting 3 months or more before seeking treatment) or Health provider delay (one 
month or more from first patient presentation till the beginning of treatment).  MA Richard et all 
had analyzed 2964 patient with a different stage of breast cancer, shown that the survival after 10 
years for patient presented less than 12 weeks after the first symptom was 52% and 47% for longer 
delays.3 
 
According to The Clinical Practice Guidelines (CPG) on the management of breast cancer 
in Malaysia, it is recommended that breast cancer patient should receive primary treatment within 
2 months of presenting symptom.4 
 
Breast cancer has a good prognosis and outcome if presented early to health care provider. 
5 years survival rate for stage 1 and stage 2 are 100% and 93% respectively, whereby stage 4 
disease only about 20%.5 This study will provide insight and understanding reason why there are 
still numbers of patient seeking treatment late for breast cancer. 
 
The aim of this study is to understand the factors associated with a delay in seeking 
treatment for patients presenting with locally advanced and metastatic breast cancer in HRPZ II. 
Thus, by understanding the reasons and its factor, a corrective action can be suggested, thus 
perhaps the rate of advanced breast cancer in HRPZ II can be reduced in the future. 
 
1.2 Literature Review. 
Literature search and review in regard to factor for delay in seeking treatment for advance 
breast cancer has been done using search engine such as SpringerLink, ScienceDirect, PubMed, 
Clinical Key, Wiley Online Library and Google Scholar. Most of the search is filtered according 
to its relevance and date of publish between 2006 to 2018. The use of connectors (AND, OR, NOT) 
with the combination of terms “delay”, “advance breast cancer”, and “factor”, has been applied in 
the searching strategy to ensure that every search is specific and effective. 
 
In year 2011, Norsa’adah et al published a cross sectional design, multicenter 
epidemiological study of delay in diagnosis of breast cancer in Malaysian woman. This study had 
shown about 49% of breast cancer patient presented at stage 3 and stage 4 disease. A median range 
for Malaysian woman who have breast cancer symptoms seek health care consultation are 2 
months. The study also found that more than half of patient (55.7%) who delay in seeking treatment 
seek alternative therapy.6 
 
 Mao Li Cheng et al (2015) found that about 59.5% of patient presented at late stage of 
breast cancer. This retrospective descriptive study also shown that only 10 patient who had 
diagnose with breast cancer had first degree relative with breast cancer, and only 4 of them had 
delay in consultation.7  
 
 Yusra Elobaid et al (2016) had found that the lack of knowledge with complex array of 
personal, social and cultural factors appear to influence a woman decision to seek clinical advice. 
This qualitative study had analyzed total of 19 patient who presented to Tawam Hospital from 
January 2010 till December 2011. The median range of consultation in 10 months while the 
frequency of diagnosis delay more than 6 months wass 52.6%.8 
 
 Mehreen Baig et al (2018) had done a cross-sectional study among breast cancer patient 
who presented to a tertiary care center in Pakistan. A total of 89 patient had being analyzed and 
55.1% of patient presented at stage 3 while 14.6% presented at stage 4. Approximately 43.8% 
patient had medical consultation within 3 to 6 months after first symptom.  This study had 
concluded that lack of knowledge about breast cancer was the most reason of delay in seeking 
treatment (41.6). this followed by non- availability of health care services near their hometown 
were second most popular reason (32.6) in delay seeking treatment. 
 
1.3 Study justification: 
Breast cancer have good prognosis and outcome if presented early. 5 years survival rate 
for stage 1 and stage 2 are 100% and 93% respectively, whereby stage 4 disease only about 20%.5 
This study will provide insight and understanding reason why there are still numbers of patient 
seeking treatment late for breast cancer. 
 
Thus, by understanding the reasons and its factor, perhaps the rate of advanced breast 
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 Understanding factors associated with delay in seeking treatment among locally advance and 
metastatic breast cancer in Hospital Raja Perempuan Zainab II  
 
INTRODUCTION: 
Breast cancer is the second most cancer common detected in the world, as reported by 
GLOBOCAN in 2012 and contribute about 25% of overall cancer worldwide.1 It is expected to 
increase every year as a lot of promotion had been done to increase breast cancer awareness. 
Despite the public awareness and education regarding breast cancer, patient with locally advanced 
breast cancer or metastatic breast cancer is still commonly seen in our community.  
In Kelantan, it had been reported by Cancer Registry 2006, up to 34.9% cases presented at 
stage 4,  comparing only 20.7% in stage 3 and 19% in stage 1.2 Breast cancer is a disease that have 
good survival rate if detected early as delay in seeking treatment associated with larger tumor, 
more advanced stage and subsequently poorer prospect of survival.  
Breast cancer delay can be defined as more than 12 weeks between discovery of the symptom 
by patient and the beginning of the definitive treatment.  This can be further classified as patient 
delay (waiting 3 months or more before seeking treatment) or health provider delay (one month or 
more from first patient presentation till beginning of treatment).  MA Richard et all had analyzed 
2964 patient with different stage of breast cancer, shown that the survival after 10 years for patient 
presented less than 12 weeks after first symptom was 52% and 47% for longer delays.3 
According to The Clinical Practice Guidelines (CPG) on management of breast cancer in 
Malaysia, it is recommended that breast cancer patient should receive primary treatment within 2 
months of presenting symptom.4 
The aim of this study is to understand the factors associated with delay in seeking treatment 
for patient presented with locally advanced and metastatic breast cancer in HRPZ II. 
PROBLEMS Statement: 
Generally, there are a lot of health promotion and breast awareness campaign that being 
held every year in Malaysia. Despite all of effort being given, there are still numbers of patient 
presented with locally advanced breast cancer or metastatic breast cancer. Thus, this study 
conducted to understand the reason why there are still patient who delay in seeking treatment and 
its related factor that associated with it. 
 
Study justification: 
Breast cancer have good prognosis and outcome if presented early. 5 years survival rate 
for stage 1 and stage 2 are 100% and 93% respectively, whereby stage 4 disease only about 20%.5 
This study will provide insight and understanding reason why there are still numbers of patient 
seeking treatment late for breast cancer. 
Thus, by understanding the reasons and its factor, perhaps the rate of advanced breast 




1. What are the sociodemographic details for patient with delay diagnosis of locally advanced 
breast cancer and metastatic breast cancer and its relationship with duration of delay in 
diagnosis 
2. What are the mean of duration of symptom before seeking treatment among locally 
advanced breast cancer and metastatic breast cancer 
3. What are the factor influencing in delay seeking treatment among locally advanced breast 
cancer and metastatic breast cancer. 







To study the factors that associated with delay in seeking treatment among advanced breast 
cancer/metastatic breast cancer. 
Specific objective: 
1. To determine the sociodemographic data associated with delay in seeking treatment 
in advanced and metastatic breast cancer patient in HRPZ II. 
2. To determine factors that have associated with delay in seeking treatment among 
patient with advanced breast cancer and metastatic breast cancer in HRPZ II 





• Low educational level, single, unemployed, seeking alternative therapy and family 
influence are an important factor that lead to delay in seeking treatment for locally 






















Literature search and review in regard to factor for delay in seeking treatment for advance breast 
cancer has been done using search engine such as SpringerLink, ScienceDirect, PubMed, Clinical 
Key, Wiley Online Library and Google Scholar. Most of the search is filtered according to its 
relevance and date of publish between 2006 to 2018. The use of connectors (AND, OR, NOT) with 
the combination of terms “delay”, “advance breast cancer”, and “factor”, has been applied in the 
searching strategy to ensure that every search is specific and effective. 
 
In year 2011, Norsa’adah et al had release a cross sectional design, multicenter 
epidemiological study of delay in diagnosis of breast cancer in Malaysian woman. This study had 
shown about 49% of breast cancer patient presented at stage 3 and stage 4 disease. A median range 
for Malaysian woman who have breast cancer symptoms seek health care consultation are 2 
months. The study also found that more than half of patient (55.7%) who delay in seeking treatment 
seek alternative therapy.6 
 
 Mao Li Cheng et al (2015) found that about 59.5% of patient presented at late stage of 
breast cancer. This retrospective descriptive study also shown that only 10 patient who had 
diagnose with breast cancer had first degree relative with breast cancer, and only 4 of them had 
delay in consultation.7 
 Yusra Elobaid et al (2016) had found that the lack of knowledge with complex array of 
personal, social and cultural factors appear to influence a woman decision to seek clinical advice. 
This qualitative study had analyzed total of 19 patient who presented to Tawam Hospital from 
January 2010 till December 2011. The median range of consultation in 10 months while the 
frequency of diagnosis delay more than 6 months wass 52.6%.8 
 Mehreen Baig et al (2018) had done a cross-sectional study among breast cancer patient 
who presented to a tertiary care center in Pakistan. A total of 89 patient had being analyzed and 
55.1% of patient presented at stage 3 while 14.6% presented at stage 4. Approximately 43.8% 
patient had medical consultation within 3 to 6 months after first symptom.  This study had 
concluded that lack of knowledge about breast cancer was the most reason of delay in seeking 
treatment (41.6). this followed by non- availability of health care services near their hometown 
were second most popular reason (32.6) in delay seeking treatment.9 
 
Methodology: 
Study Design  Cross-sectional Study 
Study Area  Hospital Raja Perempuan Zainab II (HRPZ II), 
Kota Bharu, Kelantan, Malaysia. 
Reference Population Locally advanced and Metastatic Breast cancer 
patient at HRPZ II 
Source population Locally advanced and Metastatic Breast cancer 
patients who are diagnosed at HRPZ II  
Sampling Frame Locally advanced and Metastatic Breast cancer 
patients who are diagnosed at HRPZ II from 
January 2016 till December 2019 
Study subjects  Locally advanced and Metastatic Breast cancer 
patients who are diagnosed at HRPZ II from 




Patient who presented first time to Hospital Raja Perempuan Zainab II (HRPZ II) or being referred 
from other Health Care Centre with locally advanced or Metastatic Breast cancer from 1 January 
2016 till 31st December 2019. Patient must be aged more than 18 years old and must be consented 
before conducting the interview. 
 
Exclusion Criteria 
Patient who being diagnosed earlier than January 2016 will be excluded as prior to this date the 
computerized result not yet established. Patient who did not had proper documentation of 
investigation result also will be excluded. Patient that being diagnosed as early breast cancer but 
presented again due to recurrence breast cancer also will be excluded. Patient whom did not 

















Sample Size Estimation 
1. Objective 1: Sample size being calculated using single proportion equation. 
a. Sample size =  
N = population size    
e = Margin of error  
z = z-score 
    Calculated sample size =  92 patients 
2. Objective 2: 
Sample size is calculated using pocock’s formula 
 
N = p1(1-p1)+p2(1-p2) / (p2-p1)2   
  
With: Alpha  : 0.05 , Power : 0.8 ,   Po : 0.6    P1 : 0.4 
(percentage according to incidence in Kelantan, Bachok norsa’adah 
et al(2010)) 
N = 97  
 
 
Risk factor P0 P1 N+10% Author, year 
Age  0.15 0.83 8 Bachok norsa’adah et al(2010) 
Marital status 0.19 0.8 10 Bachok norsa’adah et al(2010) 
Ethinicity  0.19 0.8 10 Bachok norsa’adah et al(2010) 
Family history 0.73 0.27 19 Bachok norsa’adah et al(2010) 
Alternative 
therapy 
0.64 0.30 37 Bachok norsa’adah et al(2010) 
 
We are planning a study of independent cases and controls with 1 control(s) per case.  Prior data 
indicate that the probability of exposure among controls is 0.6.  If the true probability of exposure 
among cases is 0.4, we will need to study  97 case patients and 97 control patients to be able to 
reject the null hypothesis that the exposure rates for case and controls are equal with probability 
(power) 0.8.   The Type I error probability associated with this test of this null hypothesis is 0.05.  
We will use an uncorrected chi-squared statistic to evaluate this null hypothesis. 
 















Workflow Of The Study 
Source Population: Locally advance Breast cancer patients  who are diagnosed at Hospital Raja 
Perempuan Zainab II 
 
Sampling frame: Locally advance Breast cancer patients  who are diagnosed at Hospital Raja 
Perempuan Zainab II 
         
Inclusion criteria fulfilled 
      
Study Sample 
      
Data entry, analysis and interpretation using SPSS 
 
Write up and research paper preparation 
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Submission of 
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1. Data Collection Method 
Request for permission will be sent to Hospital Director of HRPZ II for permission to start data 
collection for the study with the attachment of ethical clearance. Initial data will be collected 
from operation theater (OT) book from Surgical Department, medical records from Record Unit 
and histopathology result (HPE) from Pathology Unit. 
Proforma checklist will be used to extract only relevant data for this study as this study involves 
secondary data collection. Latest patients’ status (alive or death until 31st December 2019) will 
be determined through Patient Management System (SPP) for those who are still having follow up 
after 2019, case notes and phone call. Data collection will be done after MREC approval. 
Patient will be selected through convenience sampling method as they come to hospital for 
monthly clinic follow up or being admitted to surgical ward for any reason. Informed consent will 
be taken from patient before starting the interview.  The interview will take about 30 minutes. 
After completion of this study, the study result will not be reveal to the participant directly. Prior 
to starting the interview, patient will be asked either to conduct the interview alone or together 
with her relatives. 
 
2. Research Tool 
Data extraction from HRPZ II’s Record Unit and Pathology Unit 
The list of patients, who diagnosed to have advance breast cancer, will be attached with verified 
questionnaire, adopted from Bachok norsa’adah et al questionnaire(Appendix 1) and used to 
identify clinicopathological characteristics of each breast cancer patient. The list will then be 
exported to SPSS software for statistical analysis purposes. 
The questionnaire has been validated and its reliability were satisfactory (Cronbach’s Alpha 0.63-
0.92).  The permission to use questionnaire from Bachok Norsa’adah et al will be sent through 
email to its author. The letter approval from the author as per attachment in Appendix 2. 
 
Data Analysis 
Data will be entered and analyzed using SPSS version 22. Continuous data will be summarized as 
mean (standard deviation (SD)) or median (interquartile range (IGR)) depending upon the 
normality of distribution, whereas categorical data will be presented as frequency (percentage (%)). 
We will divide the diagnosis time into a binary i.e delay and non-delay, by using a 3-month cut 
off point.  
Multiple logistic regression will be use to identify the factors associated with diagnosis delay. A 
stepwise backward selection, forward selection and enter method will be use to select the 
significant variables in the model.  
The interaction terms and multicollinearity problem of the final model will be check. The final 
model will be tested for fitness using the homer-lemesshow goodness of fit test. Result will be 
presented as crude and adjusted odd ratio (OR), 95%confidence interval (Cl) and p-value. The p-
value <0.05 will be considered to indicate statistically significance. 
Expected result as follow: 
Associated factor  Delay 
(%) 







Occupation  professional      
Non professional      
Marital status  Single       
married      
divorce      
Educational level None       
Primary school      
Secondary school      
University/college      
Ethnicity  Malay      
Indian      
Chinese      
Others      
Family history of 
cancer 
Yes       
No       
Number of 
children 
None       
Less than 4      
More than 5      
First symptom Breast lump      
Breast pain      





Yes       




Yes       
No       
Factor that lead 
to delay 
Patient       
Family factor      
Neighbor/ colleague 
pressure 
     
No nearby health care 
facilities 
     




This study involves secondary data, which is data from breast cancer patients, in the HRPZ II 
Record Unit, Surgical Department and Pathology Department. 
Prior to conducting the interview, patient will be given patient information sheet in language that 
understood by the patient and to be read by them. The patient will be informed again that this study 
will not interfere with current patient management and there will be minimal risk by joining the 
study. 
 
Declaration of absence of conflict of interest 
No conflict of interest. 
 
Privacy and confidentiality 
Confidentiality of the data will be maintained at highest level as possible which only researcher 
will have the access to the data. 
All forms are anonymous and will be entered into SPSS software. Only research team members 
can access the data. Data will be presented as grouped data and will not identify the 
responders individually. 
Patient’s names will be kept on a password-protected database and will be linked only with a study 
identification number for this research. The identification number instead of patient identifiers will 
be used on subject data sheets. All data will be entered into a computer that is password protected. 
On completion of study, data in the computer will be copied to CDs and the data in the computer 
erased. CDs and any hardcopy data will be stored in a locked office of the investigators and 
maintained for a minimum of three years after the completion of the study. The CDs and data will 
be destroyed after that period of storage. Subjects will not be allowed to view their personal study 
data, as the data will be consolidated into a database. Subjects can write to the investigators to 




Publication Policy  
No personal information will be disclosed and subjects will not be identified when the findings of 
the survey are published. 
Sponsorhip and  honorarium 
This study is fully funded by Dr Mohd Firdaus Bin Akarim and patient will not receive any 




















Mempunyai penyakit lain: 0 Ya, nyatakan ............ 0 Tida'k 
Merokok: 0 Ya, berapa llama .... , berapa batang sehari ..... . 
0 bekas perokok, berapa lama ......• berapa batang sehari ..... . 
0 T ldak pemah 
C: SOALSELIDIK KELEWATAN 
Tarikh mula perasan gejala kanser payudara: D O/D O/DODO 
Apakah gejala kanser paytdara yang pertama anda alami? 
0 Benjolan 0 Sakit 0 Lelehan putting 0 Putting tertarik 0 Kudis 
0 lain-lain, nyatakan ............................. . 
T arikh mula mengadu kepada seseorang mengenai gejala kanser payudara: 
D O/D O/DODD . siapa .... ............... . 
T arikh pertama kafi berunding dengan doktor mengenai gejala kanser payudara: 
0 0/0 0/0000 , siapa ..... ........ ....... . 
Doktor beritahu ia adalah 0 kanser 0 infeksi 0 ketulan susu 0 Tidak diberitahu apa-apa 
0 lain.,iain, nyatakan ........... ........ .... ...... . 
Doktor telah 0 beri ubal 0 beri temujanji doldor pakar 0 ambil tisu 0 tunggu dahulu 
0 lain-lain, nyatakan ....................... ...... . 
Saya mengambil lkeputusan be~umpa doklor berkenaan masalah payudara kerana: 
Benjolan semakin besar D Ya 0 Tldak 
Perubahan benluk payudara 0 Ya 0 Tldak 
T erdapat Ianda baru D Ya 0 Tldak 
Saya kehilangan berat badan 0 Ya 0 liida'k 
Saya tidak lalu makan D Ya 0 Tidak 
Saya semakin ~dak bertenaga 0 Ya 0 Tidak 
Saya fidak dapat menja'lankan tugas di rumah dengan baik lagi 
Saya tidak dapat menja'lan'kan tugas di tempat ke~a dengan baik lagi 
Dinasihati oleh kawan-kawan 0 Ya 0 Tldak 
Dinasihati suami 
Dinasihati keluarga lain 
0 Ya 0 liida'k 
0 Ya 0 Tldak 
0 Ya 0 Tidak 
0 Ya 0 Ti.dak 
Saya telah mengambil tindakan berjumpa doktor dengan segera 0 Ya 0 Tidak 
Siapa yang membuat keputusan untuk berjumpa doktor? ODiri sendiri DSuami Dahft keluarg·a. nyalakan ......... 
Saya mengikuti rawatan kanser payudara dengan segera 0 Ya 0 Tidak 
Siapa yang membuat keputusan untuk mendapatkan rawatan kanser payudara: 
0 Diri sendiri 0 Suami 0 ahft keluarga, nyatakan ............. .. 
2 
 
Tiada kenderaan unluk lberjumpa doktor 0 Ya 0 Tidak 
Tidak ada wang yang cu'ku,p untuk rawatan dan kos lain 0 Ya 0 Tidia'k 
e. P·erkara mencetuskan tindakan 
Suami mendesak saya mendapatkan rawatan 
Ahfi keluarga mendesak saya mendapalkan rawalan 
Ka•.van-kawan mendesak saya mendapatkan rawatan 
Ada pengalaman warislkenaJan mengidap kanser payudara 
Apabila terdengar mengenai kanser payudara dimedia 
Apabila terbaca mengenai lkanser payudara dimedia celak 
f. K,epercayaan 
Kanser payudara berlaku pada diri saya kerana: 
Kecederaan pada payudara 
Simpulan urat 
Pemakanan yang tidak baik 
Sistem badan yang lemah 
Stress 
Kerurunan 
Asyik besflata mengenainya 
Disumpah 
Dibuat orang1 
0,: PERFORIMA REKOD 
Status: 0 hidup D mafi 0 tidak di'ketahui 
Tarik:h status: 0 0/0 0/0 0 0 0 
0 Ya 0 Tidak 
0 Ya 0 Tidak 
0 Ya 0 Tidak 
0 Ya 0 Tidak 
O Ya 0 Tidak 
0 Ya 0 Tidak 
OYa 0 Tidak 
OYa 0 Tidak 
OYa 0 Tidak 
OYa 0 Tidak 
OYa 0 Tidak 
OYa 0 Tidak 
OYa 0 Tidak 
OYa 0 Tidak 
OYa 0 Tidak 
Jika status tidak di'ketahui, larikh terakhir masih hidup: 0 0 /0 0 /D D D O 
a: Keadaan klinikal semasa diagnosa 
Berat bad an: 0 0 _ 0 kg 
Tinggi: 0.0 0 m 
Mammogram: 0 Ya, bila ------··---·-- 0 Tidak 
Kanser payudara dikesan oleh: 0 pesakit sendiri 0 kakitangan perubatan 0 mammogram 
0 !lain-lain, nyaiakan ..................... . 
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